Structural surfaceomics reveals an AML-specific conformation of integrin β2 as a CAR T cellular therapy targetKamal Mandal, Arun P. Wiita, Adila Izgutdina et al.|Nature Cancer|2023Cited by 39
Structural Surfaceomics Reveals an AML-Specific Conformation of Integrin-β2 As an Immunotherapeutic TargetKamal Mandal, Arun P. Wiita, Gianina Wicaksono et al.|Blood|2022Cited by 4
Structural surfaceomics reveals an AML-specific conformation of Integrin-β2 as a CAR-T therapy targetKamal Mandal, Arun P. Wiita, Gianina Wicaksono et al.|bioRxiv (Cold Spring Harbor Laboratory)|2022Cited by 2